Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AVTX
GYRE
Add up to 3 more stocks
AVTX
Avalo Therapeutics, Inc.
-8.63%
$13.34-1.26Delayed quote: Oct 6, 2026, 1:40 PM EDT
Market Cap
$701.23M
52W Range
$12.51 - $24.27
GYRE
Gyre Therapeutics, Inc.
-4.22%
$7.04-0.31Delayed quote: Oct 6, 2026, 1:39 PM EDT
Market Cap
$784.88M
52W Range
$5.44 - $9.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.56 | 7.27 |
| P/S Ratio | 11885.17 | 6.57 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 94.3% |
| Operating Margin | -123601.7% | 9.9% |
| Net Margin | -170055.9% | -14.5% |
| ROE | -22.4% | -13.3% |
| ROA | -20.4% | -8.7% |
| ROIC | -19.4% | -9.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 19.31 | 4.26 |
| Quick Ratio | 19.31 | 3.86 |
| Debt/Equity | 0.00 | 0.03 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.